Product Viability Report shows NeoCyte provides 11.8% increase over the current live cell manufacture
The product line includes :
Umbilical cord blood-derived cellular product
NeoCyte® is a next generation umbilical cord blood-derived cellular product containing mesenchymal Stem Cells (MSCs). In addition, this product contains UCB-derived mononuclear cells, which perform several important functions. First, these cells protect stem cells from the harsh environment of an inflamed joint or injured tissue. In addition, these mononuclear cells include immune progenitor cells that help modulate the local immune response itself.
UCB-derived mononuclear cells and Whorton’s Jelly
NeoCyte-PLUS® is a powerful combination of UCB-derived mononuclear cells and Whorton’s Jelly (WJ)-derived MSCs sourced by minimal manipulation from the same donor tissue in accordance with FDA regulations. The combination of these cells not only doubles the number of MSCs per sample, but the added power of WJ-derived MSCs adds the option for greater immune modulation when and where your patients need it most.
UCB-derived mononuclear cells with WJ-derived MSCs and Growth Factor Rich Plasma (GFRP)
NeoCyte-MAXX® is our most potent cellular product. We combine UCB-derived mononuclear cells with WJ-derived MSCs and Growth Factor Rich Plasma (GFRP) from a single source using minimal manipulation in accordance with FDA regulations. GFRP is the product sought-after in Platlet Rich Plasma (PRP), but naturally pre-activated and ready to work. PRP requires activation at the site of injury before the platlets are washed from the area. NeoCyte-MAXX® acts immediately in a potent combination of theraputic cells and growth factors.
Umbilical cord blood-derived cellular product containing mesenchymal Stem Cells (MSCs)
NeoCyte® is a next generation umbilical cord blood-derived cellular product containing mesenchymal Stem Cells (MSCs). In addition, this product contains UCB-derived mononuclear cells, which perform several important functions. First, these cells protect stem cells from the harsh environment of an inflamed joint or injured tissue. In addition, these mononuclear cells include immune progenitor cells that help modulate the local immune response itself. NeoCyte 2X offers twice the number of cells in the same volume.
Wharton’s jelly of the human cord
Wharton’s jelly of the human cord is unique among connective tissues as it contains only mesenchymal cells that comprise the functional myofibro-blasts of the tissue, and their pre-cursors. There are no other cell types described in Wharton’s jelly.
It is, therefore, possible, with the correct scientific approach, to isolate MSCs from WJ with minimal manipulation of the tissue, retaining their natural anti-inflammatory and pro-regenerative ability. A relatively high number of umbilical cord mesenchymal stem cells (UCMSCs) reside in Wharton jelly, approximately
400,000 cells per umbilical cord compared with 1 mesenchymal
stem cell in 10,000 nucleated bone marrow cells.
